Genetic Association of FABP4 with Cardiovascular Events: A Mendelian Randomization Study
Clinical and Applied Thrombosis/Hemostasis · 2025
DOI: 10.1177/10760296251401588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2025. Verfasst von Pei Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, The Second Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Mendelian Randomization Analysis, Cardiovascular Diseases. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hebei Medical Science Research Project Plan for 2024.
Abstract (Originalsprache)
Background
There is conflicting evidence of the correlation between fatty acid binding protein 4 (FABP4) and cardiovascular disease (CVD) in previous observational studies.
Objective
This study aims to explore the genetic causal association between FABP4 and adverse cardiovascular (CV) events.
Methods
A two-sample bidirectional Mendelian randomization (MR) analysis was performed using summary statistics from GWAS. The primary method used for MR analysis was the inverse-variance weighted (IVW) method, complemented by MR-Egger, weighted median, and weighted mode methods to explore the causal association between FABP4 and adverse CV events. For sensitivity analysis assessing heterogeneity and pleiotropy, MR-Egger and MR-PRESSO were employed to address horizontal pleiotropy, while Cochran's Q test was used to assess heterogeneity between instrumental variables (IVs). The leave-one-out analysis was used to detect outliers.
Results
IVW suggested that FABP4 showed no genetic causal effect on stroke (OR = 1.01, 95% CI = 0.98–1.04, p = 0.52), angina (OR = 1.0003, 95% CI = 0.9994–1.0012, p = 0.53), arrhythmia (OR = 1.0004, 95% CI = 0.9998–1.0009, p = 0.25), heart failure (OR = 0.99, 95% CI = 0.96–1.02, p = 0.53) or myocardial infarction (OR = 0.99, 95% CI = 0.97–1.01, p = 0.21). In the reverse MR analysis, IVW analysis showed no genetic causal effect of adverse CV events on FABP4. The results of other methods were consistent with the IVW method. Sensitivity analysis indicated the results was robust.
Conclusion
Our study did not find evidence to support a causal relationship between FABP4 and adverse CV events. Further studies are needed to comprehensively assess this potential association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Pei Zhang, Huaihai Lu
Förderung
- Hebei Medical Science Research Project Plan for 2024
Zitieren
APA
Zhang, P., Tian, W., Tian, Y., Yu, N., Liu, X., Liu, C., Ma, S., & Lu, H. (2025). Genetic Association of FABP4 with Cardiovascular Events: A Mendelian Randomization Study. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296251401588
Vancouver
Zhang P, Tian W, Tian Y, Yu N, Liu X, Liu C, et al. Genetic Association of FABP4 with Cardiovascular Events: A Mendelian Randomization Study. Clinical and Applied Thrombosis/Hemostasis. 2025. doi:10.1177/10760296251401588
BibTeX
@article{Zhang2025,
author = {Zhang, Pei and Tian, Wenbin and Tian, Ye and Yu, Ning and Liu, Xuefang and Liu, Chao and Ma, Shuxian and Lu, Huaihai},
title = {Genetic Association of FABP4 with Cardiovascular Events: A Mendelian Randomization Study},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2025},
doi = {10.1177/10760296251401588}
}
EUVIMED